Quarterly Accounts Receivable
$8.70 M
-$441.00 K-4.83%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly accounts receivable is currently $8.70 million, with the most recent change of -$441.00 thousand (-4.83%) on 30 September 2024. DAWN quarterly accounts receivable is now -4.83% below its all-time high of $9.14 million, reached on 30 June 2024.DAWN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
DAWN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.8% | at low | ||
| 5 y | 5 years | -4.8% | at low | ||
| alltime | all time | -4.8% | at low |
Day One Biopharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.70 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $9.14 M |
FAQ
- What is Day One Biopharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Day One Biopharmaceuticals?
What is Day One Biopharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of DAWN is $8.70 M
What is the all time high quarterly accounts receivable for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly accounts receivable is $9.14 M